在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Protein TOS6 (TOS6) CSB-YP513915SVN
CSB-EP513915SVN
CSB-BP513915SVN
CSB-MP513915SVN
CSB-EP513915SVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Required for respiratory growth protein 7, mitochondrial (RRG7) CSB-YP513916SVN
CSB-EP513916SVN
CSB-BP513916SVN
CSB-MP513916SVN
CSB-EP513916SVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondrial morphogenesis protein SLD7 (SLD7) CSB-YP513917SVN
CSB-EP513917SVN
CSB-BP513917SVN
CSB-MP513917SVN
CSB-EP513917SVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae ASTRA-associated protein 1 (ASA1) CSB-YP513918SVN
CSB-EP513918SVN
CSB-BP513918SVN
CSB-MP513918SVN
CSB-EP513918SVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Crotalus atrox Zinc metalloproteinase/disintegrin VMP-II CSB-YP513919DYC
CSB-EP513919DYC
CSB-BP513919DYC
CSB-MP513919DYC
CSB-EP513919DYC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C9orf172 (C9orf172), partial CSB-YP513920HU
CSB-EP513920HU
CSB-BP513920HU
CSB-MP513920HU
CSB-EP513920HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative uncharacterized protein C19orf81 (C19orf81) CSB-YP513921HU
CSB-EP513921HU
CSB-BP513921HU
CSB-MP513921HU
CSB-EP513921HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative claudin-25 (CLDN25), partial CSB-YP513922HU1
CSB-EP513922HU1
CSB-BP513922HU1
CSB-MP513922HU1
CSB-EP513922HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HERV-H LTR-associating protein 1 (HHLA1) CSB-YP513923HU
CSB-EP513923HU
CSB-BP513923HU
CSB-MP513923HU
CSB-EP513923HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Aldo-keto reductase family 1 member B15 (AKR1B15) CSB-YP513924HU(F2)
CSB-EP513924HU(F2)
CSB-BP513924HU(F2)
CSB-MP513924HU(F2)
CSB-EP513924HU(F2)-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative aminoacrylate peracid reductase RutC (rutC) CSB-YP513925ENN
CSB-EP513925ENN
CSB-BP513925ENN
CSB-MP513925ENN
CSB-EP513925ENN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus vulcanius 2-phospho-L-lactate guanylyltransferase (cofC) CSB-YP513926MRW
CSB-EP513926MRW
CSB-BP513926MRW
CSB-MP513926MRW
CSB-EP513926MRW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fibrobacter succinogenes 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA (cpdA) CSB-YP513927FER
CSB-EP513927FER
CSB-BP513927FER
CSB-MP513927FER
CSB-EP513927FER-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Signal peptidase complex catalytic subunit SEC11 (SEC11), partial CSB-YP513928VES1
CSB-EP513928VES1
CSB-BP513928VES1
CSB-MP513928VES1
CSB-EP513928VES1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Probable Xaa-Pro aminopeptidase VDBG_02538 (VDBG_02538) CSB-YP513929VES
CSB-EP513929VES
CSB-BP513929VES
CSB-MP513929VES
CSB-EP513929VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Probable dipeptidyl-aminopeptidase B (DAPB), partial CSB-YP513930VES
CSB-EP513930VES
CSB-BP513930VES
CSB-MP513930VES
CSB-EP513930VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Anionic peptide CSB-YP513931TOM
CSB-EP513931TOM
CSB-BP513931TOM
CSB-MP513931TOM
CSB-EP513931TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative neurotoxin Na8 CSB-YP513932TOM
CSB-EP513932TOM
CSB-BP513932TOM
CSB-MP513932TOM
CSB-EP513932TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 4-hydroxyphenylacetate decarboxylase activating enzyme (hpdA) CSB-YP513933DUO
CSB-EP513933DUO
CSB-BP513933DUO
CSB-MP513933DUO
CSB-EP513933DUO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis Cell division inhibitor SulA (sulA) CSB-YP513934DXZ
CSB-EP513934DXZ
CSB-BP513934DXZ
CSB-MP513934DXZ
CSB-EP513934DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.51tesewang.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>